Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-05

Clinical Trial Update: Melatonin Loaded in Injectable Platelet-Rich Fibrin in the Management Periodontitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating melatonin delivered via Injectable Platelet-Rich Fibrin for managing periodontitis; currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin-loaded Injectable Platelet-Rich Fibrin (melatonin)

Snippet

Sponsor: Al-Azhar University | Conditions: Periodontitis Stage II | Phase 4 | Status: ENROLLING_BY_INVITATION